Somatic TARDBP variants identified in human brain with FTLD-TDP-C disrupt morphology and microglia numbers in zebrafish

Abstract Pathogenic germline variants in TARDBP can cause amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Recently, we identified somatic TARDBP variants in the brains of two individuals with semantic dementia and FTLD-TDP type C pathology. These two somatic variants (L41F and R42H) were identified in the N-terminal domain of TARDBP , whereas the vast majority of functional studies so far have focused on C-terminal variants, in which other known pathogenic germline variants are located. We assessed the pathogenicity of the somatic N-terminal variants in vivo using zebrafish in direct comparison to germline TARDBP variants causing ALS and FTLD-TDP (P112H, K263E, and I383V). In line with in silico predictions, we show that somatic variant L41F is poorly tolerated in in vivo toxicity assays, resulting in a toxic gain-of-function when ubiquitously expressed. Furthermore, L41F showed substantial loss-of-function in rescue experiments performed in tardbp -deficient background. Germline variant K263E showed similar outcomes, while somatic variant R42H and germline variant I383V demonstrated lower levels of toxicity and loss-of-function in these assays. An increase in microglia was detected with overexpression of R42H mRNA compared to wild-type, indicating a potential immunogenic effect. Additionally, we created a novel germline N-terminal tardbp single amino acid deletion (G37del) in zebrafish, which caused severe morphological abnormalities. In conclusion, these data provide evidence of the pathogenicity of N-terminal variants, including L41F and R42H, found as somatic variants in FTLD-TDP C, and suggest that possibly germline variants in this domain may not be compatible with life. This might contribute to the absence of pathogenic N-terminal variants in patients, and further reinforces the importance of considering somatic contributions in FTLD-TDP.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica Communications
Published
2026-10-05
DOI
https://doi.org/10.1186/s40478-026-02417-5
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Somatic TARDBP variants identified in human brain with FTLD-TDP-C disrupt morphology and microglia numbers in zebrafish

John Cornelis Van Swieten, Tjakko J. van Ham, Jeroen van Rooij, Merel O. Mol et al.
Acta Neuropathologica Communications
Amyotrophic Lateral Sclerosis Research
article

Somatic TARDBP variants identified in human brain with FTLD-TDP-C disrupt morphology and microglia numbers in zebrafish

John Cornelis Van Swieten, Tjakko J. van Ham, Jeroen van Rooij, Merel O. Mol, Tahsin Stefan Barakat, Ana Rajicic, Leslie E. Sanderson, Shamiram Melhem, Herma C. van der Linde
article en

Abstract

Abstract Pathogenic germline variants in TARDBP can cause amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). Recently, we identified somatic TARDBP variants in the brains of two individuals with semantic dementia and FTLD-TDP type C pathology. These two somatic variants (L41F and R42H) were identified in the N-terminal domain of TARDBP , whereas the vast majority of functional studies so far have focused on C-terminal variants, in which other known pathogenic germline variants are located. We assessed the pathogenicity of the somatic N-terminal variants in vivo using zebrafish in direct comparison to germline TARDBP variants causing ALS and FTLD-TDP (P112H, K263E, and I383V). In line with in silico predictions, we show that somatic variant L41F is poorly tolerated in in vivo toxicity assays, resulting in a toxic gain-of-function when ubiquitously expressed. Furthermore, L41F showed substantial loss-of-function in rescue experiments performed in tardbp -deficient background. Germline variant K263E showed similar outcomes, while somatic variant R42H and germline variant I383V demonstrated lower levels of toxicity and loss-of-function in these assays. An increase in microglia was detected with overexpression of R42H mRNA compared to wild-type, indicating a potential immunogenic effect. Additionally, we created a novel germline N-terminal tardbp single amino acid deletion (G37del) in zebrafish, which caused severe morphological abnormalities. In conclusion, these data provide evidence of the pathogenicity of N-terminal variants, including L41F and R42H, found as somatic variants in FTLD-TDP C, and suggest that possibly germline variants in this domain may not be compatible with life. This might contribute to the absence of pathogenic N-terminal variants in patients, and further reinforces the importance of considering somatic contributions in FTLD-TDP.

Acta Neuropathologica Communications
Erasmus MC (NL)
Openalex Percentile: Top 12%
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.